Compare NEPH & FNUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEPH | FNUC |
|---|---|---|
| Founded | 1997 | 2018 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Other Metals and Minerals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.4M | 54.2M |
| IPO Year | 2004 | 2019 |
| Metric | NEPH | FNUC |
|---|---|---|
| Price | $4.42 | $1.43 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | 33.1K | ★ 309.7K |
| Earning Date | 05-08-2026 | 06-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1000.00 | N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $18,789,000.00 | N/A |
| Revenue This Year | $11.24 | N/A |
| Revenue Next Year | $11.58 | N/A |
| P/E Ratio | $37.25 | ★ N/A |
| Revenue Growth | ★ 32.67 | N/A |
| 52 Week Low | $2.66 | $1.35 |
| 52 Week High | $6.42 | $2.82 |
| Indicator | NEPH | FNUC |
|---|---|---|
| Relative Strength Index (RSI) | 52.81 | 37.89 |
| Support Level | $3.99 | $1.41 |
| Resistance Level | $4.70 | $1.85 |
| Average True Range (ATR) | 0.32 | 0.09 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 46.66 | 15.71 |
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.
Frontier Nuclear and Minerals Inc is developing a U.S.-focused front-end nuclear fuel cycle company through a portfolio of U.S. uranium exploration and development projects in Wyoming, Colorado, and Utah, together with investments in next-generation uranium enrichment and small modular reactors. Frontier Nuclear is actively evaluating value-accretive investment opportunities in other sectors of the domestic U.S. nuclear fuel cycle. The group is developing a portfolio of critical minerals projects in America, Canada, and Namibia, including uranium, tantalum, cesium, and lithium. Its projects are Engo Valley, Pine Ridge, Shatford Lake, Snow Lake Lithium, and Tallahassee.